glp 1 cease and desist The promise peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Glucagon-like peptide-1 receptor: mechanisms and

By DEE-ANN DURBIN AP Business Writer Meals and snacks with GLP-1 Friendly labels on the packaging are becoming more common in U.S

Missing a single semaglutide injection won't derail your weight loss progress, but timing matters for appetite control and metabolic stability

See how weight loss programs from Ro can offer lasting, effective weight loss results.

China had 947 GLP-1 clinical trials in 2025

Powered by AI and backed by 10+ years of expertise, it helps marketing authorization holders navigate high volumes of unstructured data, off-label use, and regulatory scrutiny all while improving operational efficiency

Indias drug regulator has issued a strict advisory prohibiting direct and indirect promotion of prescription weight-loss drugs, including digital campaigns, influencer endorsements and disease-awareness initiatives that could act as surrogate advertising